Improvement in insulin sensitivity during mifepristone treatment of Cushing syndrome: early and late effects.
作者信息
Wallia Amisha, Colleran Kathleen, Purnell Jonathan Q, Gross Coleman, Molitch Mark E
出版信息
Diabetes Care. 2013 Sep;36(9):e147-8. doi: 10.2337/dc13-0246.
Abstract
摘要
相似文献
1
Improvement in insulin sensitivity during mifepristone treatment of Cushing syndrome: early and late effects.米非司酮治疗库欣综合征期间胰岛素敏感性的改善：早期和晚期效应
Diabetes Care. 2013 Sep;36(9):e147-8. doi: 10.2337/dc13-0246.
2
Mifepristone (Korlym) for Cushing's syndrome.用于库欣综合征的米非司酮（科立纯）
Med Lett Drugs Ther. 2012 Jun 11;54(1392):46-7.
3
Medical management of Cushing's syndrome.库欣综合征的医学管理。
Endocr Pract. 2013 Mar-Apr;19(2):193. doi: 10.4158/EP12262.ED.
4
The use of mifepristone in the treatment of Cushing's syndrome.米非司酮在库欣综合征治疗中的应用。
Drugs Today (Barc). 2012 Aug;48(8):509-18. doi: 10.1358/dot.2012.48.8.1841299.
5
MIFEPRISTONE AND CUSHING SYNDROME: A COMMENTARY.米非司酮与库欣综合征：一篇评论
Endocr Pract. 2015 Oct;21(10):1175-7. doi: 10.4158/EP15888.OR.
6
Medical treatment of Cushing's syndrome: glucocorticoid receptor antagonists and mifepristone.库欣综合征的治疗：糖皮质激素受体拮抗剂和米非司酮。
Neuroendocrinology. 2010;92 Suppl 1:125-30. doi: 10.1159/000314224. Epub 2010 Sep 10.
7
Mifepristone: treatment of Cushing's syndrome.米非司酮：库欣综合征的治疗
Clin Obstet Gynecol. 1996 Jun;39(2):506-10. doi: 10.1097/00003081-199606000-00024.
8
Sustained weight loss in patients treated with mifepristone for Cushing's syndrome: a follow-up analysis of the SEISMIC study and long-term extension.米非司酮治疗库欣综合征患者的持续体重减轻：SEISMIC研究及长期扩展的随访分析
BMC Endocr Disord. 2015 Oct 27;15:63. doi: 10.1186/s12902-015-0059-5.
9
The use of the glucocorticoid receptor antagonist mifepristone in Cushing's syndrome.米非司酮在库欣综合征中的应用。
Curr Opin Endocrinol Diabetes Obes. 2012 Aug;19(4):295-9. doi: 10.1097/MED.0b013e32835430bf.
10
Mifepristone for management of Cushing's syndrome.米非司酮治疗库欣综合征。
Pharmacotherapy. 2013 Mar;33(3):319-29. doi: 10.1002/phar.1202. Epub 2013 Feb 21.
引用本文的文献
1
Multiple Clinical Indications of Mifepristone: A Systematic Review.米非司酮的多种临床适应症：一项系统评价。
Cureus. 2023 Nov 6;15(11):e48372. doi: 10.7759/cureus.48372. eCollection 2023 Nov.
2
Medical treatment of Cushing's disease with concurrent diabetes mellitus.库欣病合并糖尿病的治疗。
Front Endocrinol (Lausanne). 2023 Apr 17;14:1174119. doi: 10.3389/fendo.2023.1174119. eCollection 2023.
3
Cortisol and cardiometabolic disease: a target for advancing health equity.皮质醇与心脏代谢疾病：促进健康公平的目标。
Trends Endocrinol Metab. 2022 Nov;33(11):786-797. doi: 10.1016/j.tem.2022.08.002. Epub 2022 Oct 18.
4
Mifepristone Improves Adipose Tissue Insulin Sensitivity in Insulin Resistant Individuals.米非司酮可改善胰岛素抵抗个体的脂肪组织胰岛素敏感性。
J Clin Endocrinol Metab. 2021 Apr 23;106(5):1501-1515. doi: 10.1210/clinem/dgab046.
5
Medical Treatment of Cushing's Disease: An Overview of the Current and Recent Clinical Trials.库欣病的治疗：当前和近期临床试验概述。
Front Endocrinol (Lausanne). 2020 Dec 8;11:648. doi: 10.3389/fendo.2020.00648. eCollection 2020.
6
Clinical management of patients with Cushing syndrome treated with mifepristone: consensus recommendations.米非司酮治疗库欣综合征患者的临床管理：共识推荐
Clin Diabetes Endocrinol. 2020 Oct 29;6(1):18. doi: 10.1186/s40842-020-00105-4.
7
Diabetes Mellitus Secondary to Cushing's Disease.库欣病继发的糖尿病
Front Endocrinol (Lausanne). 2018 Jun 5;9:284. doi: 10.3389/fendo.2018.00284. eCollection 2018.
8
Diabetes in Cushing Disease.库欣病中的糖尿病
Curr Diab Rep. 2017 May;17(5):32. doi: 10.1007/s11892-017-0860-9.
9
Serum Adiponectin Level as a Predictor of Subclinical Cushing's Syndrome in Patients with Adrenal Incidentaloma.血清脂联素水平作为肾上腺偶发瘤患者亚临床库欣综合征的预测指标
Int J Endocrinol. 2016;2016:8519362. doi: 10.1155/2016/8519362. Epub 2016 Aug 30.
10
Sustained weight loss in patients treated with mifepristone for Cushing's syndrome: a follow-up analysis of the SEISMIC study and long-term extension.米非司酮治疗库欣综合征患者的持续体重减轻：SEISMIC研究及长期扩展的随访分析
BMC Endocr Disord. 2015 Oct 27;15:63. doi: 10.1186/s12902-015-0059-5.
本文引用的文献
1
Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing's syndrome.米非司酮，一种糖皮质激素受体拮抗剂，可给库欣综合征患者带来临床和代谢获益。
J Clin Endocrinol Metab. 2012 Jun;97(6):2039-49. doi: 10.1210/jc.2011-3350. Epub 2012 Mar 30.
2
The relationship between {beta}-cell function and glycated hemoglobin: results from the veterans administration genetic epidemiology study.β细胞功能与糖化血红蛋白的关系：来自退伍军人管理局遗传流行病学研究的结果。
Diabetes Care. 2011 Apr;34(4):1006-10. doi: 10.2337/dc10-1352. Epub 2011 Feb 23.
3
Mortality and morbidity in Cushing's disease over 50 years in Stoke-on-Trent, UK: audit and meta-analysis of literature.英国特伦特河畔斯托克 50 多年来库欣病的死亡率和发病率：审计和文献荟萃分析。
J Clin Endocrinol Metab. 2011 Mar;96(3):632-42. doi: 10.1210/jc.2010-1942. Epub 2010 Dec 30.
4
Pathophysiology of diabetes mellitus in Cushing's syndrome.库欣综合征糖尿病的病理生理学。
Neuroendocrinology. 2010;92 Suppl 1:77-81. doi: 10.1159/000314319. Epub 2010 Sep 10.
5
Assessment of insulin sensitivity and beta-cell function from measurements in the fasting state and during an oral glucose tolerance test.通过在空腹状态和口服葡萄糖耐量试验期间的测量来评估胰岛素敏感性和β细胞功能。
Diabetologia. 2000 Dec;43(12):1507-11. doi: 10.1007/s001250051561.
Zotero 插件